--- title: 'Associate Director, Statistical Programming at Definium Therapeutics' canonical: 'https://feeny.ai/job/associate-director-statistical-programming-definium-therapeutics-remote-32hes91t3fd9' type: 'job' last_seen: '2026-10-13' --- # Associate Director, Statistical Programming at Definium Therapeutics - **Company:** Definium Therapeutics - **Location:** Remote - **Compensation:** $155k–$195k - **Work type:** remote - **Posted:** 2026-09-24 - **Last confirmed live:** 2026-10-13 - **Apply:** https://job-boards.greenhouse.io/definiumtherapeutics/jobs/6207911004 ## Job description Definium Therapeutics is a late-stage clinical biopharmaceutical company and our mission is to forge a new era of psychiatry by applying scientific rigor to psychedelics, with the goal of developing accessible treatments that unlock healing at scale. Our lead product candidate, lysergide tartrate (our proprietary orally disintegrating tablet form of lysergide (LSD) D-tartrate), represents a highly differentiated, potential best-in-class opportunity for patients suffering from generalized anxiety, major depressive disorder, and posttraumatic stress disorder. Our early stage pipeline includes DT402, the R-enantiomer of MDMA and is under development to target the core symptoms of autism spectrum disorder (ASD), specifically addressing social communication challenges. Guided by the recognition that patients deserve more than better, Definium is relentlessly advancing a new generation of therapeutics intended to address the underlying causes of psychiatric and neurological disorders. By turning evidence into impact, Definium aims to change the trajectory of today’s mental health care crisis and enable a healthier future. Headquartered in New York, Definium Therapeutics trades on Nasdaq under the symbol DFTX. Together we are moving psychiatry forward—beyond better, into a boundless future. Join us! As Associate Director, Statistical Programming, this role will provide statistical programming support for compounds at different stages of development, including clinical development, regulatory filing, and commercialization. Reporting to Director, Statistical Programming Lead, this role will serve as the study lead programmer for assigned clinical trial(s), and work closely with study statistician, data management, and other functions within the study team to provide statistical programming support as needed. Working with the study lead biostatistician, this individual will oversee the deliverables from statistical vendors to ensure high quality and meeting timelines. Additionally, this role will perform statistical data analyses and partner with the Clinical Data Management group to support data cleaning activities. Responsibilities: - Serve as the study lead programmer for assigned clinical trial(s), and work closely with study statistician, data management, and other functions within the study team to provide statistical programming support as needed - Review and ensure high quality of Define packages including aCRF, SDTM/ADaM datasets, Pinnacle 21 reports, cSDRG/ADRG, and define XML for assigned clinical trial(s) - Review and ensure high quality of Define packages for integrated datasets from meeting CDISC standards to meeting regulatory requirements as part of electronic submission - Work closely with study lead biostatistician to manage vendor’s deliverables from quality to timeline - Perform independent validation (QC) to ensure accuracy of statistical vendor’s deliverables from datasets to analytic outputs - Perform independent validation (QC) to ensure accuracy of analytic outputs produced by internal biostatisticians or statistical programmers - Work closely with Clinical Data Management colleagues to produce systematic data reports to support efficient clinical trial data review and cleaning - Review CRF and/or Data Transfer Specification to ensure that data collection will meet the study objectives, requirements, and standards in CDISC format - Provide input to Statistical Analysis Plans and TLF Shells for Tables/Listings/Figures - Perform statistical analysis to support publications, and/or regulatory correspondence as needed - Perform other duties as assigned Qualifications and Skills: - Master's Degree in Biostatistics, Statistics, Computer Science or other relevant fields with at least 12 years of experience in providing statistical programming support in clinical trial setting - Deep understanding about data standards with rich experience in understanding Pinnacle 21 validation report and creating Define XML packages to support regulatory filing - Proficient in statistical computational software such as SAS, including complicated data steps, SAS macro languages, and commonly used analysis procedures (e.g., PROC Freq, PROC REPORT, PROC GLM, and PROC MIXED) - Demonstrated capacity of collaboration with biostatisticians, Clinical Data Management and colleagues from other functions to deliver common goals - Strong organizational and project management skills demonstrated interest in continued learning and growing - Proven to work well on multiple projects in a fast-paced environment - Detail-oriented and hold high standards of excellence for Statistical Programming’s  deliverables - Deliver and communicate effectively in the work-from-home environment - Excellent interpersonal skills and a good team player Preferred Experience: - Experience in data structure and data analysis in CNS clinical trials - Experience in providing integrated data analysis support in regulatory filing Compensation will be determined based on several factors including, but not limited to, skill set, years of experience, and the employee’s geographic location. Employees in this role may be entitled to additional compensation, including bonus and equity. Benefits information is listed on our Jobs Page. The Company provides competitive benefits to employees including: - 100% paid health benefits including Medical, Dental and Vision for you and your dependents - 401(k) program with company match and vesting after the turn of the first month after your start date - Flexible time off - Generous parental leave and some fun fringe perks! The starting base pay range for this position: $155,000—$195,000 USD ## About Definium Therapeutics ## Company Overview - **One-liner**: Definium Therapeutics is a clinical-stage biopharmaceutical company applying scientific rigor to psychedelic medicine to develop accessible treatments for psychiatric disorders. - **Entity Type**: Public (NASDAQ: DFTX) - **Headquarters**: Not specified in available sources; the company operates as a remote-first organization. - **Founded**: 2019 (originally as MindMed) - **Founders**: Not publicly available in provided sources. ## Core Business - **Primary Industry**: Biotechnology / Psychiatric drug development (psychedelic medicine) - **Target Customers**: Patients with major depressive disorder (MDD), generalized anxiety disorder (GAD), posttraumatic stress disorder (PTSD), and autism spectrum disorder (ASD); also healthcare providers and payers. - **Mission/Purpose**: “Unlock healing at scale” by harnessing the full therapeutic potential of psychedelic medicine through precise, evidence-based science. ## Products & Services - **DT120 ODT (Lysergide/LSD D-Tartrate Oral Disintegrating Tablet)**: Investigational drug for GAD, MDD, and PTSD. Currently in four Phase 3 trials (Voyage, Panorama, Emerge, Ascend) and a fifth planned for PTSD. FDA Breakthrough Therapy Designation for GAD. No adjunctive psychotherapy required. - **DT402 (R(-)-MDMA)**: R-enantiomer of MDMA selected for serotonergic properties with a potentially superior tolerability profile. In Phase 2a study for social communication challenges in autism spectrum disorder. ## Market Standing - **Valuation/Market Cap**: Not publicly available (publicly listed on NASDAQ as DFTX as of 2026, but recent market cap not provided in search results). - **Key Metric**: Pre-revenue clinical-stage company; total funding history not disclosed in available sources. - **Notable Investors/Partners**: Not disclosed in provided sources. - **Growth Signals**: - Five Phase 3 trials ongoing or planned for DT120 ODT. - FDA Breakthrough Therapy Designation for DT120 in GAD. - Phase 2a trial initiated for DT402 in ASD. - Full results from Phase 2b GAD trial published in JAMA (2025). - Strong intellectual property with issued patents covering formulation, manufacturing, and treatment. ## Competitive Advantages - **Proprietary Formulations**: Pharmaceutically optimized ODT for LSD (DT120) and novel R-enantiomer of MDMA (DT402) with potential improved tolerability. - **Scientific Rigor**: Standalone drug studies without psychotherapy, enabling clearer efficacy and safety data. - **Regulatory Momentum**: FDA Breakthrough Therapy Designation and multiple IND clearances. - **Experienced Management Team**: Proven track record in developing and commercializing CNS therapies. - **Comprehensive IP Strategy**: Patents covering drug formulations, methods of manufacture, and treatment use. ## Strategic Focus - **Late-Stage Pipeline Advancement**: Completing Phase 3 trials for GAD and MDD, initiating PTSD trial. - **Pipeline Expansion**: Advancing DT402 for ASD and exploring additional neuropsychiatric indications. - **Commercial Readiness**: Building infrastructure (hiring VP of Sales, Senior Director of Field VEOR, etc.) to support potential future launch. - **Data Generation**: Generating high-quality evidence to support regulatory submissions and differentiation. ## Why Work Here - **Remote-First Culture**: “You can live anywhere in the country you’re employed in” (remote-first workforce). - **Comprehensive Benefits**: 100% paid medical, dental, vision for employees and dependents; FSA/HSA; life and disability insurance. - **Wellness & Time Off**: Annual wellness allowance, flexible PTO, company-wide shutdowns for rest. - **Family Support**: Paid parental leave for birthing and non-birthing parents, 2-week return-to-work transition. - **Financial Wellness**: Competitive compensation, 401(k) with employer match, employee equity (new hire grants and refreshes), Employee Stock Purchase Plan (ESPP) with discount. - **Mission-Driven Work**: Opportunity to contribute to groundbreaking treatments in psychedelic psychiatry with a science-driven, collaborative team. ## Sources 1. [definiumtx.com](https://definiumtx.com/) – Company overview and pipeline details 2. [definiumtx.com](https://definiumtx.com/story/) – Company history, leadership, and strategic milestones 3. [definiumtx.com](https://definiumtx.com/careers/) – Careers page with benefits and remote-first policy 4. [definiumtx.com](https://definiumtx.com/research-development/) – Research and development pipeline details 5. [linkedin.com](https://www.linkedin.com/company/definiumtherapeutics) – LinkedIn company page ## Other roles at Definium Therapeutics - [Manager, Data & Analytics](https://feeny.ai/job/manager-data-analytics-definium-therapeutics-remote-1myd7q4ncfyq) - [Sr. Director, Sales Training](https://feeny.ai/job/sr-director-sales-training-definium-therapeutics-remote-4e05xqacax1x) - [Director, Pharmaceutical Development, Drug Product Manufacturing](https://feeny.ai/job/director-pharmaceutical-development-drug-product-manufacturing-definium-a61y0sjn24be) - [Director, Regulatory Affairs (Advertising and Promotions)](https://feeny.ai/job/director-regulatory-affairs-advertising-and-promotions-definium-therapeutics-yttv1kff5hzj) - [Staff Accountant](https://feeny.ai/job/staff-accountant-definium-therapeutics-remote-crzmf7hrv4fn) - [Director, Talent Acquisition Commercial](https://feeny.ai/job/director-talent-acquisition-commercial-definium-therapeutics-remote-6gnxe2cb0ac7) - [Director, Supply and Distribution Quality](https://feeny.ai/job/director-supply-and-distribution-quality-definium-therapeutics-remote-6hf75zdnx5pq) - [Director, Medical Communications](https://feeny.ai/job/director-medical-communications-definium-therapeutics-remote-35fwkadvgv4y) - [Director, Patient Services Operations](https://feeny.ai/job/director-patient-services-operations-definium-therapeutics-raleigh-durham-b25ndrr3vznf) — Raleigh/durham, NC - [Director, Patient Services Patient Strategy](https://feeny.ai/job/director-patient-services-patient-strategy-definium-therapeutics-remote-2ht8ekq69e73)